President Donald Trump announced sweeping changes to fertility care access Wednesday, including fertility drug discounts of up to 2,320% and new employer benefit options. The White House initiatives aim to slash IVF costs that can reach $25,000 per cycle.
The moves address a critical healthcare gap affecting one in eight couples struggling with infertility. With U.S. fertility at historic lows and limited insurance coverage, many families face financial barriers to treatment.
The centerpiece involves EMD Serono, a major fertility drug manufacturer, agreeing to “Most-Favored-Nation” (MFN) pricing, which aligns U.S. prices with the lowest rates paid by other developed nations. Under the agreement, GONAL-F, a commonly used fertility medication, will be available through TrumpRx.gov at a 796% discount from the deal price.
Low- and middle-income women earning below 550% of the Federal Poverty Level (FPL) will receive an additional discount totaling 2,320% when purchasing through the federal site.
The Centers for Medicare and Medicaid Services (CMS) estimates women can save up to $2,200 per cycle on fertility drugs that often cost over $5,000, which represent roughly 20% of the total expense for a fertility treatment cycle.
EMD Serono also committed to manufacture IVF drugs in the United States for the first time and extend MFN-level discounts to future innovative medicines. The company pledged to offer other medications at deep discounts, guarantee MFN prices on all new products, and provide every state Medicaid program access to those rates.
The Food and Drug Administration (FDA) will include a lower-cost European fertility medication in the Commissioner’s National Priority Review Voucher Program, cutting review time for approval from 10–12 months to just 1–2 months. If approved under the expedited timeline, the drug would bring additional competition and lower prices to the U.S. market.
The administration also announced a new Benefit Option allowing employers to offer standalone fertility benefit packages similar to dental or vision coverage. Currently, only 32% of employers offer IVF coverage despite 70% of large companies providing such benefits. The Departments of Labor, Health and Human Services, and Treasury will undertake additional rulemaking to expand these fertility-benefit pathways further.
Trump framed the initiatives as fulfilling campaign promises to support family formation.
“Because we want more babies — to put it very nicely,” the president said, acknowledging that “IVF treatments are expensive.”
The president’s earlier Working Families Tax Cuts created Trump Accounts providing $1,000 investments for newborns and expanded Child Tax Credits supporting 40 million families.
Fertility-benefit providers report nearly 25% higher live-birth rates among patients using employer-sponsored coverage compared with those paying privately. Officials said additional guidance will be issued in 2026 to continue expanding fertility access nationwide.